Managing risks in drug discovery: reproducibility of published findings
about
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-MycReplication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression dataReplication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsReplication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.Talking the talk, but not walking the walk: RT-qPCR as a paradigm for the lack of reproducibility in molecular research.The reproducibility issue and preclinical academic drug discovery: educational and institutional initiatives fostering translation success.International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.Translatability score revisited: differentiation for distinct disease areas.Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells.The development of ruthenium(ii) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications.cCMP and cUMP Across the Tree of Life: From cCMP and cUMP Generators to cCMP- and cUMP-Regulated Cell Functions.Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms
P2860
Q28559676-A0B56689-FFED-4B9D-9C75-6EE5333ECB76Q28559693-60534735-3743-4D19-AC04-3315FB9B2DB2Q28559700-F906E3A8-FA47-439F-965E-861ED1F65693Q33842529-13C310DB-91C1-49B9-9A76-E8DAD5BB6D99Q38630683-C8C308CF-DE3E-46A4-AF2A-0E8DE1F7789AQ38893034-FCDA14B9-BF30-4A31-A216-096A84A70D75Q39158851-82BC6180-B6BA-48AF-A272-BE3255CB8DA3Q47101734-2B2068EA-559F-43A3-AA8A-02C5FED3A7C7Q48290610-7DBBC823-8C7E-4041-9C96-4D30DAF2283EQ49611544-5AFEBAF4-99AD-40A6-931D-979C2B6C73BBQ50456694-0409CB9A-2826-4AB0-B1EF-63585100F52BQ58646940-59EAD8AD-989B-4DE2-928E-D231577299F8
P2860
Managing risks in drug discovery: reproducibility of published findings
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Managing risks in drug discovery: reproducibility of published findings
@ast
Managing risks in drug discovery: reproducibility of published findings
@en
Managing risks in drug discovery: reproducibility of published findings
@en-gb
Managing risks in drug discovery: reproducibility of published findings
@nl
type
label
Managing risks in drug discovery: reproducibility of published findings
@ast
Managing risks in drug discovery: reproducibility of published findings
@en
Managing risks in drug discovery: reproducibility of published findings
@en-gb
Managing risks in drug discovery: reproducibility of published findings
@nl
prefLabel
Managing risks in drug discovery: reproducibility of published findings
@ast
Managing risks in drug discovery: reproducibility of published findings
@en
Managing risks in drug discovery: reproducibility of published findings
@en-gb
Managing risks in drug discovery: reproducibility of published findings
@nl
P2860
P921
P1476
Managing risks in drug discovery: reproducibility of published findings
@en
P2093
Aimo Kannt
P2860
P2888
P304
P356
10.1007/S00210-016-1216-8
P407
P577
2016-04-01T00:00:00Z
P5875
P6179
1052867975